PFM
Privium Fund Management Portfolio holdings
AUM
$464M
This Quarter Return
+31.78%
1 Year Return
+124.83%
3 Year Return
+508.69%
5 Year Return
–
10 Year Return
–
AUM
$464M
AUM Growth
+$464M
(+21%)
Cap. Flow
-$4.03M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
81.5%
Holding
63
New
7
Increased
24
Reduced
7
Closed
8
Top Buys
| 1 |
Coinbase
COIN
|
$24.2M |
| 2 |
Tesla
TSLA
|
$6.79M |
| 3 |
Biogen
BIIB
|
$2.67M |
| 4 |
Amazon
AMZN
|
$1.76M |
| 5 |
Shopify
SHOP
|
$1.71M |
Top Sells
| 1 |
Spotify
SPOT
|
$23.1M |
| 2 |
Snowflake
SNOW
|
$7.13M |
| 3 |
Cloudflare
NET
|
$6.76M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$5.47M |
| 5 |
uniQure
QURE
|
$1.84M |
Sector Composition
| 1 | Consumer Discretionary | 30.56% |
| 2 | Technology | 23.32% |
| 3 | Healthcare | 20.6% |
| 4 | Communication Services | 18.3% |
| 5 | Financials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Spotify
SPOT
$140B
| $84.8M | 18.3% | 114,000 -31,000 | -21% | -$23.1M |
|
|
2
Tesla
TSLA
$1.08T
| $74.7M | 16.11% | 242,000 +22,000 | +10% | +$6.79M |
|
|
3
Shopify
SHOP
$184B
| $49M | 10.57% | 430,000 +15,000 | +4% | +$1.71M |
|
4
Palantir
PLTR
$372B
| $46.6M | 10.05% | 350,000 -10,000 | -3% | -$1.33M |
|
|
5
Amazon
AMZN
$2.44T
| $32.8M | 7.07% | 149,000 +8,000 | +6% | +$1.76M |
|
6
Sea Limited
SE
$110B
| $32.5M | 7.01% | 210,000 | – | – |
|
|
7
Coinbase
COIN
$78.2B
| $24.2M | 5.22% | +70,000 | New | +$24.2M |
|
8
NVIDIA
NVDA
$4.24T
| $12.5M | 2.7% | 81,000 +8,000 | +11% | +$1.24M |
|
9
Ionis Pharmaceuticals
IONS
$6.79B
| $10.7M | 2.31% | 267,594 | – | – |
|
10
ProQR Therapeutics
PRQR
$237M
| $10M | 2.17% | 4,997,562 +11,929 | +0.2% | +$24K |
|
11
Arrowhead Research
ARWR
$3.05B
| $9.85M | 2.13% | 612,214 -17,000 | -3% | -$274K |
|
12
Ultragenyx Pharmaceutical
RARE
$2.89B
| $9.18M | 1.98% | 253,304 +3,500 | +1% | +$127K |
|
|
13
uniQure
QURE
$896M
| $6.26M | 1.35% | 447,486 -131,653 | -23% | -$1.84M |
|
14
Axsome Therapeutics
AXSM
$6.05B
| $5.43M | 1.17% | 52,732 | – | – |
|
15
Merck
MRK
$210B
| $4.83M | 1.04% | 59,093 +18,000 | +44% | +$1.47M |
|
16
Arcutis Biotherapeutics
ARQT
$1.86B
| $4.74M | 1.02% | 344,472 +18,763 | +6% | +$258K |
|
17
Zai Lab
ZLAB
$3.68B
| $4.65M | 1% | 132,189 | – | – |
|
18
Vertex Pharmaceuticals
VRTX
$100B
| $3.75M | 0.81% | 8,300 | – | – |
|
19
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.17M | 0.68% | 148,400 | – | – |
|
20
Moderna
MRNA
$9.37B
| $2.97M | 0.64% | 103,433 +27,857 | +37% | +$799K |
|
|
21
Biogen
BIIB
$19.4B
| $2.67M | 0.58% | +20,500 | New | +$2.67M |
|
22
CRISPR Therapeutics
CRSP
$4.71B
| $2.17M | 0.47% | 44,700 -15,397 | -26% | -$747K |
|
23
Ambev
ABEV
$34.9B
| $1.93M | 0.42% | 795,786 -8,420 | -1% | -$20.4K |
|
24
Carvana
CVNA
$51.4B
| $1.68M | 0.36% | +5,000 | New | +$1.68M |
|
25
UroGen Pharma
URGN
$900M
| $1.4M | 0.3% | 107,622 | – | – |
|